GSK RSV Vaccine Gets AdComm Nod for Older Adults
GSK's Respiratory Syncytial Virus (RSV) vaccine received a unanimous recommendation from the Advisory Committee (AdComm) for use in older adults. This approval places GSK in direct competition with existing products from Pfizer and Moderna in the RSV vaccine market.
Topics
Developing
- 872d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 872d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 872d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 872d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Source Alpha
Source Bravo
Source Charlie
Source Delta
Source Echo
Source Foxtrot
Source Golf
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade